Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 4/20 | 0.59 |
| ▸ | CES1 | P23141 | 3/20 | 0.52 |
| ▸ | GPR84 | Q9NQS5 | 2/20 | 0.50 |
| ▸ | PPARG | P37231 | 2/20 | 0.50 |
| ▸ | PPARD | Q03181 | 2/20 | 0.50 |
| ▸ | PPARA | Q07869 | 2/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.50 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.50 |
| ▸ | TLR2 | O60603 | 1/20 | 0.50 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4816366 | 1.00 | CES2 (0.59) | CES2CES1GPR84PPARGPPARD | |
| SCHEMBL16008252 | 1.00 | CES2 (0.59) | CES2CES1GPR84PPARGPPARD | |
| SCHEMBL9465217 | 1.00 | CES2 (0.59) | CES2CES1GPR84PPARGPPARD | |
| SCHEMBL3939399 | 1.00 | CES2 (0.59) | CES2CES1GPR84PPARGPPARD | |
| SCHEMBL9463727 | 1.00 | CES2 (0.59) | CES2CES1GPR84PPARGPPARD | |
| SCHEMBL5936351 | 1.00 | CES2 (0.59) | CES2CES1GPR84PPARGPPARD | |
| SCHEMBL2734730 | 1.00 | CES2 (0.59) | CES2CES1GPR84PPARGPPARD | |
| SCHEMBL9054385 | 1.00 | CES2 (0.59) | CES2CES1GPR84PPARGPPARD | |
| SCHEMBL9463930 | 1.00 | CES2 (0.59) | CES2CES1GPR84PPARGPPARD | |
| SCHEMBL5936374 | 1.00 | CES2 (0.59) | CES2CES1GPR84PPARGPPARD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 66 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119661831-A | Compositions and methods for targeted RNA delivery | 维乎医疗有限公司 | 2025-03-21 | — | — | CN | claimed |
| CN-119365189-A | Cationic lipid nanoparticle with high transfection efficiency and preparation method thereof | 北京多纳医药科技有限公司 | 2025-01-24 | — | — | CN | claimed |
| CN-115960180-A | 2019-nCoV S protein mutant and genetically engineered mRNA and vaccine composition thereof | 北京启辰生生物科技有限公司 | 2023-04-14 | — | — | CN | claimed |
| CN-115957187-A | Lipid nanoparticle composition and drug delivery system prepared from same | 北京启辰生生物科技有限公司 | 2023-04-14 | — | — | CN | claimed |
| CN-115745788-A | Ionizable lipid compound and preparation method and application thereof | 国家纳米科学中心 | 2023-03-07 | — | — | CN | claimed |
| CN-119955825-A | Polynucleotides, compositions and methods for genome editing | 因特利亚治疗公司 | 2025-05-09 | — | — | CN | disclosed |
| WO-2025083657-A1 | LIPID COMPOUND AND COMPOSITION FOR TISSUE-SPECIFIC DELIVERY OF ACTIVE SUBSTANCE | 한국생명공학연구원 | 2025-04-24 | — | — | WO | disclosed |
| CN-119836474-A | Method for editing KLKB1 in vivo | 因特利亚治疗公司 | 2025-04-15 | — | — | CN | disclosed |
| CN-119768401-A | Bicyclic tetrahydrothiazepine derivatives | 豪夫迈·罗氏有限公司 | 2025-04-04 | — | — | CN | disclosed |
| CN-119698413-A | Bicyclic tetrahydrothiazepine derivatives | 豪夫迈·罗氏有限公司 | 2025-03-25 | — | — | CN | disclosed |
| CN-119661831-A | Compositions and methods for targeted RNA delivery | 维乎医疗有限公司 | 2025-03-21 | — | — | CN | disclosed |
| CN-119604610-A | Vectors and methods for in vivo antibody production | 瑞泽恩制药公司 | 2025-03-11 | — | — | CN | disclosed |
| US-5225590-A | Alkoxy methyl ether and alkoxy methyl ester derivatives | SYNTEX (U.S.A.) INC. (US) | 1993-07-06 | — | — | US | disclosed |
| EP-0187297-B1 | ALKOXY METHYL ETHER AND ALKOXY METHYL ESTER DERIVATIVES | SYNTEX (U.S.A.) INC. (US) | 1991-08-21 | — | — | EP | disclosed |
| WO-1991007168-A1 | RIBOFLAVIN AS A TANNING ENHANCER | SCHERING-PLOUGH HEALTHCARE PRODUCTS, INC. (US) | 1991-05-30 | — | — | WO | disclosed |
| WO-1991007167-A1 | PROTEIN KINASE ACTIVATORS AS ENHANCERS OF MELANIN PRODUCTION | SCHERING-PLOUGH HEALTHCARE PRODUCTS, INC. (US) | 1991-05-30 | — | — | WO | disclosed |
| US-4885285-A | FOR THE PROPHYLAXIS AND TREATMENT OF VIRAL INFECTIONS; MYXOBACTERIUM, INFLUENZA, HERPES | CIBA-GEIGY CORPORATION (US) | 1989-12-05 | — | — | US | disclosed |
| EP-0187297-A2 | Alkoxy methyl ether and alkoxy methyl ester derivatives | SYNTEX (U.S.A.) INC. (US) | 1986-07-16 | — | — | EP | disclosed |
| EP-0174912-A2 | Phosphorus compounds, process for their preparations and their use | CIBA-GEIGY AG (CH) | 1986-03-19 | — | — | EP | disclosed |
| US-3988446-A | Glycerides with anti-inflammatory properties | ABBOTT LABORATORIES (US) | 1976-10-26 | — | — | US | disclosed |